Fatal vascular leak syndrome with extensive hemorrhage, peripheral neuropathy and reactive erythrophagocytosis: An unusual complication of recombinant IL-3 therapy

Leukemia and Lymphoma

Volumn 20, Issue 3-4, 1996, Pages 337-340

  Hurwitz, Nina ^a   Probst, Alphonse ^a   Zufferey, Guillaume ^a   Tichell, André ^a   Pless, Miklos ^a   Kappos, Ludwig ^a   Speck, Bruno ^a   Gratwohl, Alois ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Aplastic anemia; Cytokines; Neuropathy; Peripheral; rhiL 3; Vascular leak

Indexed keywords

RECOMBINANT INTERLEUKIN 3;

APLASTIC ANEMIA; ARTICLE; BLEEDING; BONE MARROW; CASE REPORT; CLINICAL TRIAL; ERYTHROPHAGOCYTOSIS; FEMALE; HUMAN; LYMPH NODE; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN DEFECT; SPLEEN;

ADULT; ANEMIA, APLASTIC; EDEMA; FEMALE; HEMORRHAGE; HUMANS; INTERLEUKIN-3; LYMPH NODES; NERVOUS SYSTEM DISEASES; RECOMBINANT PROTEINS;

EID: 0029586795     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609051628     Document Type: Article

References (12)

1. Nissen, C., Gratwohl, A. and Speck, B. (1991) Management of aplastic anemia. Eur. J. Haematol., 46, 193-197.
2. Kurzrock, R., Talpaz, M., Estrov, Z. et al. (1991) Phase I study of recombinant human interleukin-3 in patients with bone marrow failure. J. Clin. Oncol., 9, 1241-1250.
3. Ganser, A., Lindemann, A., Seipelt, G. et al. (1990) Effects of recombinant human Interleukin-3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood, 76, 666-676.
4. Edwards, M. J., Abney, D. L., Heniford, B. T. et al. (1992). Passive immunization against tumor necrosis factor inhibits interleukin-2 induced microvascular alterations and reduces toxicity. Surgery 112, 480-486.
5. Cannistra, S. A., Vellenga, E., Groshek, P. et al. (1988) Human granulocyte-monocyte colony-stimulating factor and interleukin-3 stimulate monocyte cytotoxicity through a tumor necrosis factor-dependent mechanism. Blood, 71, 672-678.
6. Dyck, P. J., Giannini, C., Lais, A. (1993) Pathologic alterations of nerves. In: Dyk, P. J., Thomas, P. K. (eds). Peripheral Neuropathy, 3rd ed., W. B. Saunders Company. Philadelphia, London, Toronto, Mexico City, Rio de Janeiro, Sydney, Tokyo, 571-572.
7. Bigelow, N. H. and Graves, R. W. (1952) Peripheral-nerve lesions in hemorrhatic diseases. Arch. Neurol. Psychiat., 68, 819-830.
8. Chalgren, W. S. (1953) Neurologic complications of the hemorrhagic disease. Neurology, 3, 126-136.
9. Herrmann, F., Lindemann, A., Lange, W. et al. (1991) Medullary histiocytosis following treatment of severe aplastic anemia with recombinant human interleukin-3 in combination with antilymphocyte globulin, cyclosporin A, and methylprednisolone. Ann. Hematol., 63, 229-231.
10. Wilson, P. A., Ayscue, L. H., Jones, G. R. et al. (1993) Bone marrow histiocytic proliferation in association with colony-stimulating factor therapy. Am. J. Clin. Path., 99, 311-313.
11. Suster, S., Hilsenbeck, S. and Rywlin, A. M. (1988) Reactive histiocytic hyperplasia with hemophagocytosis in hematopoietic organs: a reevaluation of the benign hemophagocytic proliferations. Hum. Pathol., 19, 705-712.
12. Tichelli, A., Gratwohl, A., Nissen, C. et al. (1994) Late clonal complications in severe aplastic anemia. Leukemia and Lymphoma, 12, 167-175.